N2off宣布完成与针对耐药癌症的药物研发公司的合并,包括胰腺癌和非小细胞肺癌。
N2off宣布完成与针对耐药癌症的药物研发公司的合并,包括胰腺癌和非小细胞肺癌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.